单侧聋干预临床试验结局域与工具的系統综述
共识别520个结局域和344种独特结局工具,发现结局域和工具报告存在很大变异性,报告常遗漏拟评估的结局域及所用工具信息。
要点
- 言语相关结局域最常见(74%研究),其次为空间相关域(60%研究)。
- 共报告344种独特结局工具,言语域用73种、空间域用43种工具测量。
- 随访时长从基线急性测试至干预后10年不等,变异性大。
核心结论
- 评估单侧聋干预疗效与危害的研究在结局域和工具报告上存在很大变异性。
- 报告常遗漏研究拟评估的结局域以及用何种工具测量哪些结局域的信息。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE、PubMed、CINAHL、ClinicalTrials.gov、ISRCTN、CENTRAL、WHO ICTRP和NIHR UK临床试验门户,覆盖1946年至2020年3月发表的记录。
- 纳入标准为招募18岁及以上、较差耳平均阈值严重度差于70 dB HL且较好耳听力正常或近正常的单侧聋成人,评估恢复双侧和/或双耳听力的干预,采用对照试验、前后研究或交叉研究设计。
主要发现
- 完全纳入研究中,37项仅评估重建双侧听力的干预,29项仅评估恢复双耳听力的干预。
- 共识别520个结局域(350个主要和170个次要),言语相关结局域最常见(74%研究),其次为空间相关域(60%研究)。
- 共报告344种独特结局工具,言语相关结局域由73种不同工具测量,空间相关域由43种不同工具测量。
- 随访时长从基线急性测试至干预后10年不等,变异性相当大。
- 敏感性分析未识别出额外结局域。
临床怎么用
- 提示开展单侧聋干预确证性试验时,应基于本综述发现的结局域和工具变异性,审慎设计结局选择与报告。
- 报告应明确说明研究拟评估的结局域以及测量各结局域所用工具,避免遗漏关键信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This systematic review aimed to identify, compare and contrast outcome domains and outcome instruments reported in studies investigating interventions that seek to restore bilateral (two-sided) and/or binaural (both ears) hearing in adults with single-sided deafness (SSD). Findings can inform the development of evidence-based guidance to facilitate design decisions for confirmatory trials. METHODS: Records were identified by searching MEDLINE, EMBASE, PubMed, CINAHL, ClinicalTrials.gov, ISRCTN, CENTRAL, WHO ICTRP and the NIHR UK clinical trials gateway. The search included records published from 1946 to March 2020. Included studies were those as follows: (a) recruiting adults aged 18 years or older diagnosed with SSD of average threshold severity worse than 70 dB HL in the worse-hearing ear and normal (or near-normal) hearing in the better-hearing ear, (b) evaluating interventions to restore bilateral and/or binaural hearing and (c) enrolling those adults in a controlled trial, before-and-after study or cross-over study. Studies that fell just short of the participant eligibility criteria were included in a separate sensitivity analysis. RESULTS: Ninety-six studies were included (72 full inclusion, 24 sensitivity analysis). For fully included studies, 37 exclusively evaluated interventions to re-establish bilateral hearing and 29 exclusively evaluated interventions to restore binaural hearing. Overall, 520 outcome domains were identified (350 primary and 170 secondary). Speech-related outcome domains were the most common (74% of studies), followed by spatial-related domains (60% of studies). A total of 344 unique outcome instruments were reported. Speech-related outcome domains were measured by 73 different instruments and spatial-related domains by 43 different instruments. There was considerable variability in duration of follow-up, ranging from acute (baseline) testing to 10 years after the intervention. The sensitivity analysis identified no additional outcome domains. CONCLUSIONS: This review identified large variability in the reporting of outcome domains and instruments in studies evaluating the therapeutic benefits and harms of SSD interventions. Reports frequently omitted information on what domains the study intended to assess, and on what instruments were used to measure which domains. TRIAL REGISTRATION: The systematic review protocol is registered on PROSPERO (International Prospective Register of Systematic Reviews): Registration Number CRD42018084274 . Registered on 13 March 2018, last revised on 7th of May 2019.
引用
- Katiri R, Hall DA, Killan CF, et al. Systematic review of outcome domains and instruments used in designs of clinical trials for interventions that seek to restore bilateral and binaural hearing in adults with unilateral severe to profound sensorineural hearing loss ('single-sided deafness'). Trials. 2021. PMID: 33743802. doi:10.1186/s13063-021-05160-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。